SMT201500184B - Sistema terapeutico transdermico per somministrareun principio attivo - Google Patents

Sistema terapeutico transdermico per somministrareun principio attivo

Info

Publication number
SMT201500184B
SMT201500184B SM201500184T SM201500184T SMT201500184B SM T201500184 B SMT201500184 B SM T201500184B SM 201500184 T SM201500184 T SM 201500184T SM 201500184 T SM201500184 T SM 201500184T SM T201500184 B SMT201500184 B SM T201500184B
Authority
SM
San Marino
Prior art keywords
administer
active ingredient
therapeutic system
transdermal therapeutic
transdermal
Prior art date
Application number
SM201500184T
Other languages
English (en)
Inventor
Der Britta Schr
Bj Rn Schurad
Heike Hausner
Original Assignee
Acino Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acino Ag filed Critical Acino Ag
Publication of SMT201500184B publication Critical patent/SMT201500184B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SM201500184T 2010-12-14 2015-07-31 Sistema terapeutico transdermico per somministrareun principio attivo SMT201500184B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP10194968.3A EP2468274B1 (de) 2010-12-14 2010-12-14 Transdermales therapeutisches System zur Verabreichung eines Wirkstoffs

Publications (1)

Publication Number Publication Date
SMT201500184B true SMT201500184B (it) 2015-09-07

Family

ID=43836835

Family Applications (1)

Application Number Title Priority Date Filing Date
SM201500184T SMT201500184B (it) 2010-12-14 2015-07-31 Sistema terapeutico transdermico per somministrareun principio attivo

Country Status (25)

Country Link
US (2) US10660863B2 (it)
EP (2) EP2468274B1 (it)
JP (1) JP6043296B2 (it)
KR (1) KR101842309B1 (it)
CN (3) CN107412202A (it)
AU (2) AU2011343363B2 (it)
BR (1) BR112013014616B1 (it)
CA (2) CA3065240C (it)
CY (2) CY1116638T1 (it)
DK (2) DK2468274T3 (it)
EA (1) EA026520B1 (it)
ES (2) ES2545094T3 (it)
HK (1) HK1243336A1 (it)
HR (2) HRP20150881T1 (it)
HU (2) HUE027916T2 (it)
LT (1) LT2651410T (it)
MX (1) MX345344B (it)
MY (1) MY183873A (it)
PL (2) PL2468274T3 (it)
PT (2) PT2468274E (it)
RS (2) RS54173B1 (it)
SI (2) SI2468274T1 (it)
SM (1) SMT201500184B (it)
WO (1) WO2012080365A1 (it)
ZA (1) ZA201303965B (it)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102012000369A1 (de) * 2012-01-11 2013-07-11 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Transdermales therapeutisches System mit Cholinesterase-Hemmer
DE102012016317A1 (de) 2012-08-14 2014-02-20 Jenabatteries GmbH Redox-Flow-Zelle zur Speicherung elektrischer Energie
JP2015530375A (ja) * 2012-08-15 2015-10-15 ダウ コーニング コーポレーションＤｏｗ Ｃｏｒｎｉｎｇ Ｃｏｒｐｏｒａｔｉｏｎ 多層薬物送達システム
WO2014111790A2 (en) * 2013-01-15 2014-07-24 Zydus Technologies Limited Stable transdermal pharmaceutical drug delivery system comprising rivastigmine
US20240082065A1 (en) * 2016-07-08 2024-03-14 Moteah Williams Waterproof and transparent wound barrier and method of manufacturing same
EP3501518A4 (en) 2016-08-22 2020-04-29 Kyukyu Pharmaceutical Co., Ltd. TRANSDERMAL PATCH
US20210085633A1 (en) * 2017-07-19 2021-03-25 Teikoku Seiyaku Co., Ltd. Rivastigmine-containing transdermal absorption preparation
DE102018120506A1 (de) * 2017-10-20 2019-04-25 Amw Gmbh Stabilisiertes transdermales Darreichungssystem
DE102017127433A1 (de) * 2017-11-21 2019-05-23 Lts Lohmann Therapie-Systeme Ag TTS auf Basis von klebenden Weichmacher-Polymer-Matrices
JP2021517572A (ja) * 2018-03-13 2021-07-26 エルテーエス ローマン テラピー−ジステーメ アーゲー シリコーンアクリルハイブリッドポリマーを含む経皮治療システム
CN111885992B (zh) * 2018-05-17 2023-12-08 松下知识产权经营株式会社 生物体贴附用选择性透过膜、透皮吸收套件和美容方法
EP3513965B1 (en) 2018-08-08 2022-05-04 Danapak Flexibles A/S Improved films and laminates for use in packaging reactive compounds
KR20200025888A (ko) 2018-08-31 2020-03-10 에스케이케미칼 주식회사 장기 투여용 리바스티그민 패취
KR20200025883A (ko) 2018-08-31 2020-03-10 에스케이케미칼 주식회사 장기 투여용 리바스티그민 패취
BR112021023509A2 (pt) * 2019-07-09 2022-01-18 Lts Lohmann Therapie Systeme Ag Sistema terapêutico transdérmico compreendendo uma camada contendo o agente ativo compreendendo um polímero acrílico e uma camada de contato com a pele compreendendo um adesivo de gel de silicone
CN113616625B (zh) * 2021-08-26 2023-05-30 大连科翔科技开发有限公司 一种卡巴拉汀的长效透皮贴剂

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU201906B (en) 1987-03-04 1991-01-28 Sandoz Ag Process for producing phenyl-carbamate derivative and acid additional salts and pharmaceutical compositions containing them
EP0656771A4 (en) * 1992-08-25 1996-07-31 Cygnus Therapeutic Systems DEVICE FOR TRANSDERMAL DRUG DELIVERY.
JPH0912448A (ja) * 1995-04-28 1997-01-14 Read Chem Kk 薬物放出制御型経皮吸収製剤
GB9800526D0 (en) 1998-01-12 1998-03-11 Ciba Geigy Ag Organic compounds
US6348210B1 (en) * 1998-11-13 2002-02-19 Alza Corporation Methods for transdermal drug administration
DE19918106A1 (de) 1999-04-22 2000-10-26 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit neutralisierten Acrylathaftklebern
DE10033853A1 (de) 2000-07-12 2002-01-31 Hexal Ag Transdermales therapeutisches System mit hochdispersem Siliziumdioxid
DE10103860B4 (de) * 2001-01-30 2004-12-23 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System für die Verabreichung carboxylgruppenhaltiger, nichtsteroidaler Antiphlogistika, sowie Verfahren zu seiner Herstellung
DE10141652B4 (de) 2001-08-24 2011-04-07 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System auf der Basis von Polyacrylat-Haftklebern ohne funktionelle Gruppen und seine Verwendung
DE10141650C1 (de) * 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
US8252320B2 (en) 2004-10-21 2012-08-28 Durect Corporation Transdermal delivery system for sufentanil
EP1814531B1 (en) * 2004-10-21 2010-06-16 Durect Corporation Transdermal delivery systems
TWI389709B (zh) 2005-12-01 2013-03-21 Novartis Ag 經皮治療系統
CA2634975A1 (en) * 2005-12-30 2007-07-12 Coloplast A/S A layered adhesive construct having a mouldable layer as skin contact surface
CN101304735A (zh) * 2006-01-12 2008-11-12 Lts勒曼治疗系统股份公司 用于挥发性和/或热不稳定的物质的经皮治疗体系
MY149152A (en) 2006-05-08 2013-07-15 Teikoku Seiyaku Kk Percutaneous absorption preparations of antimentia drugs
US9248104B2 (en) * 2006-08-17 2016-02-02 Core Tech Solutions, Inc. Transdermal methods and systems for treating Alzheimer's disease
DE102006054731B4 (de) * 2006-11-21 2013-02-28 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Verabreichung des Wirkstoffs Buprenorphin und Verwendung desselben in der Schmerztherapie
WO2009009651A1 (en) * 2007-07-10 2009-01-15 Agile Therapeutics, Inc. Dermal delivery device with ultrasonic weld
WO2009026135A2 (en) * 2007-08-17 2009-02-26 Alza Corporation Controlled transdermal bisoprolol delivery system
EP2255802B1 (en) * 2008-02-27 2018-01-17 Hisamitsu Pharmaceutical Co., Inc. Adhesive skin patch and packaged product
US20090291127A1 (en) * 2008-05-21 2009-11-26 Jianye Wen Transdermal anti-dementia active agent formulations and methods for using the same
JP2010126450A (ja) * 2008-11-25 2010-06-10 Lintec Corp 経皮吸収貼付剤
DK2515886T3 (en) * 2009-12-22 2018-06-14 Luye Pharma Ag Transdermal therapeutic system for administration of rivastigmine or derivatives thereof

Also Published As

Publication number Publication date
AU2011343363A1 (en) 2013-06-20
KR20130129988A (ko) 2013-11-29
JP6043296B2 (ja) 2016-12-14
ES2836483T3 (es) 2021-06-25
CA3065240C (en) 2022-02-15
RS54173B1 (en) 2015-12-31
EA201300704A1 (ru) 2014-01-30
CN113244199A (zh) 2021-08-13
AU2017213569A1 (en) 2017-08-31
US20200289426A1 (en) 2020-09-17
CY1116638T1 (el) 2017-03-15
PL2651410T3 (pl) 2021-03-08
MY183873A (en) 2021-03-17
PT2468274E (pt) 2015-09-21
US10660863B2 (en) 2020-05-26
CN103269698A (zh) 2013-08-28
DK2468274T3 (en) 2015-08-31
DK2651410T3 (da) 2020-11-02
AU2011343363B2 (en) 2017-06-08
US20140323996A1 (en) 2014-10-30
AU2017213569B2 (en) 2019-04-11
CN103269698B (zh) 2017-07-14
HRP20201880T1 (hr) 2021-02-05
EP2651410B1 (de) 2020-10-14
MX345344B (es) 2017-01-26
PT2651410T (pt) 2020-12-15
EP2468274A1 (de) 2012-06-27
HUE027916T2 (en) 2016-11-28
SI2651410T1 (sl) 2021-01-29
EP2651410A1 (de) 2013-10-23
HRP20150881T1 (hr) 2015-09-25
ES2545094T3 (es) 2015-09-08
EA026520B1 (ru) 2017-04-28
KR101842309B1 (ko) 2018-03-26
ZA201303965B (en) 2014-09-25
HUE052137T2 (hu) 2021-04-28
MX2013005581A (es) 2013-08-26
PL2468274T3 (pl) 2015-11-30
BR112013014616B1 (pt) 2021-12-21
HK1243336A1 (zh) 2018-07-13
SI2468274T1 (sl) 2015-10-30
CA2817461A1 (en) 2012-06-21
EP2468274B1 (de) 2015-07-01
BR112013014616A2 (pt) 2016-09-20
CY1123712T1 (el) 2022-03-24
RS61155B1 (sr) 2020-12-31
CA2817461C (en) 2020-02-25
WO2012080365A1 (de) 2012-06-21
LT2651410T (lt) 2020-12-28
CA3065240A1 (en) 2012-06-21
CN107412202A (zh) 2017-12-01
JP2014503523A (ja) 2014-02-13

Similar Documents

Publication Publication Date Title
SMT201500184B (it) Sistema terapeutico transdermico per somministrareun principio attivo
CO7000779A2 (es) Sistema de administración transdermica
SMT201500232B (it) Dispositivo per la somministrazione de farmaci
DK3639872T3 (da) Lægemiddeladministrationsanordning
SMT201600219B (it) Ormone follicolo-stimolante ricombinante umano migliorato
BR112015003376A8 (pt) composto ou sal farmaceuticamente aceitável do mesmo, composição farmacêutica e usos de quantidade eficiente de composto ou sal farmaceuticamente aceitável do mesmo ou composição farmacêutica
DK3489220T3 (da) Lipider til terapeutisk middel-leveringsformuleringer
BR112013012156A2 (pt) sistema terapêutico transdérmico e método de produção de um sistema terapêutico transdérmico
DK2632493T3 (da) Lægemiddelindgivelsessammensætninger
DK3527241T3 (da) Indretning til administration af lægemiddel
ES2689151T8 (es) Sistema de electroencefalografía implantable e inalámbrico
DK2819726T3 (da) Medikamentadministrationsanordning med fast dosis
DK2652652T3 (da) Medikmentadministration
DK2600924T3 (da) Enhed til medicinafgivelsesanordning
BRPI1005433A2 (pt) preparações farmacêuticas transdérmicas
DK2353632T3 (da) Medicinsk anordning til lokal lægemiddelafgivelse
ZA201403497B (en) Transdermal therapeutic system for administering fentanyl or analogue thereof
BR112013029199A2 (pt) sistema de distribuição de fármacos, dispositivo de distribuição de dois fármacos, método para preparar o mesmo, comprimido para administração sublingual de um ingrediente ativo, e, método para a administração de um ingrediente ativo a um indivíduo
DK2750673T3 (da) Transdermalt terapeutisk system for 5-aminolevulinsyrehydrochlorid
DK2621561T3 (da) Fleksibelt fastgørelsesmiddel til lægemiddeladministrationsanordning
BR112014013309A8 (pt) parte superior de cânula e sistema
EP2567710A4 (en) AQUEOUS PHARMACEUTICAL SYSTEM FOR THE ADMINISTRATION OF ACTIVE SUBSTANCES ON THE NAILS
DK2420219T3 (da) Indgivelsesport
BR112013033052A2 (pt) formulações de entrega de fármaco
AP3390A (en) Therapeutic vaccination against active tuberculosis